J. Uemasu et al., SUPPRESSION OF PLASMA ENDOTHELIN-1 LEVEL BY ALPHA-HUMAN ATRIAL-NATRIURETIC-PEPTIDE AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN NORMAL MEN, Life sciences, 53(11), 1993, pp. 969-974
The effect of synthetic alpha-human atrial natriuretic peptide (alpha-
hANP) on plasma endothelin-1 (ET-1) level was examined in 6 healthy su
bjects. Intravenous infusion of alpha-ANP (0.1 mug/kg/min) resulted in
significant falls in plasma renin activity and aldosterone, but witho
ut effect on ET-1 level. An angiotensin converting enzyme inhibitor, c
aptopril, increased plasma renin activity and decreased aldosterone, r
espectively. However, plasma ET-1 levels were not modified by captopri
l. In cases with alpha-hANP infusion after captopril (25 mg, p.o.,), t
he renin-angiotensin-aldosterone system was further inhibited compared
with the first group, and ET- 1 at 60 min was significantly suppresse
d from the baseline. These data suggest that alpha-hANP when combined
with captopril brings about the suppression of plasma ET- 1 concentrat
ions in men.